(Q53191415)
Statements
Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study (English)
Sun Hwa Kim
Sin Gon Kim
Doo Man Kim
Jeong-Taek Woo
Hak Chul Jang
Kyung Soo Ko
Jeong Hyun Park
Yong Soo Park
Sang Jin Kim
Dong Seop Choi
21 September 2015